Kidney transplant recipients research hub
3 indexed studies · 1 currently recruiting
- completedNot Applicable
Testing the ability to reduce immunosuppression in older renal transplant recipients
This study looks at whether older adults having a kidney transplant can safely take lower doses of anti-rejection medicines. Lower doses may help reduce the risk of serious infections while still keeping the new kidney safe. Researchers will closely monitor patients using new, gentle blood tests.
United Kingdom · England - recruitingTherapeutic exploratory (Phase II)
Acute effects of SGLT2 inhibitor on kidney allograft oxygen tension: A randomized, double-blind, placebo controlled crossover trial
This study is looking at how a medicine called Jardiance affects oxygen levels in transplanted kidneys. We want to see if it can help these kidneys work better by improving their oxygen supply, using special MRI scans to measure this.
Denmark - authorisedTherapeutic exploratory (Phase II)
SGL-TX-PTDM: SGLT2i effect on PTDM development and kidney allograft function in kidney transplant recipients: A randomized, double-blind, placebo controlled, national multicenter trial
This study looks at how a drug called Forxiga affects new diabetes and kidney health in people who've had a kidney transplant. It compares Forxiga to a dummy pill to see if it makes a difference over 6 to 12 months.
Denmark